Tobrex

Bacteria, Cystic Fibrosis, Septicemia + 19 more

Treatment

1 Active Study for Tobrex

What is Tobrex

Tobramycin

The Generic name of this drug

Treatment Summary

Tobramycin is an antibiotic that is used to treat infections caused by bacteria, including Pseudomonas aeruginosa. It can be given as an inhalant, intravenous injection, or as eye drops. While it is generally effective, it can cause side effects such as nephrotoxicity and ototoxicity. Tobramycin was approved by the FDA in 1975 and is available in a variety of forms.

Tobrex

is the brand name

image of different drug pills on a surface

Tobrex Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Tobrex

Tobramycin

1981

166

Effectiveness

How Tobrex Affects Patients

Tobramycin is an antibiotic used to treat a wide range of bacterial infections, including some biothreat agents. Taking tobramycin can be risky because it can cause damage to the kidneys, ears, and nerves. It can also affect a baby in the womb, leading to permanent hearing loss. All tobramycin formulations carry a risk of allergic reactions, which can sometimes be fatal.

How Tobrex works in the body

Tobramycin works by binding to the cell membranes of bacteria. It increases the permeability of the cell, allowing it to enter the cell and target the bacterial cells' ribosomes, which are responsible for making proteins. This causes proteins to be made incorrectly, leading to the destruction of the cell. Bacteria can become resistant to tobramycin by modifying the ribosome or the tobramycin molecule itself. Tobramycin is also not effective against anaerobic bacteria since it requires active transport across bacterial membranes.

When to interrupt dosage

The suggested dosage of Tobrex is contingent upon the determined circumstance, including Cystic Fibrosis (CF), steroid-responsive inflammation and Meningitis, Bacterial. The amount of dosage can be found in the table below, in accordance with the method of administration.

Condition

Dosage

Administration

concomitant use of NSAID

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Inflammation

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Cystic Fibrosis

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Bacterial Infections

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Burkholderia Cepacia Infection

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Bacterial Peritonitis

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

FEV1 <25% predicted

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Septicemia

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Conjunctivitis

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Urinary tract infection

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Eye Infections, Bacterial

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Otitis

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

External auditory canal structure

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

FEV1 >80% predicted

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Eye Infections

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Cystic Fibrosis

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Bacteria

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

ocular bacterial infections

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Adrenal Cortex Hormones

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Intraabdominal Infections

, 0.003 mg/mg, 40.0 mg/mL, 300.0 mg/mL, 0.8 mg/mL, 10.0 mg/mL, 3.0 mg/mL, 120.0 mg/mL, 0.3 %, 1200.0 mg, 28.0 mg, 80.0 mg, 60.0 mg, 1.2 mg/mL, 60.0 mg/mL, 170.0 mg

, Ointment, Ointment - Ophthalmic, Ophthalmic, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Solution, Oral, Solution - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Solution - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Solution - Respiratory (inhalation), Respiratory (inhalation), Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Respiratory (inhalation), Liquid - Intramuscular; Intravenous, Liquid, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection - Intravenous, Solution / drops - Ophthalmic, Solution / drops, Suspension, Suspension - Ophthalmic, Capsule - Oral; Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Liquid - Intravenous, Solution - Oral; Respiratory (inhalation), Liquid - Ophthalmic, Oral; Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation)

Warnings

Tobrex exhibits one contraindication, so it should not be administered in combination with the conditions outlined in the following table.

Tobrex Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Tobrex.

Common Tobrex Drug Interactions

Drug Name

Risk Level

Description

Neomycin

Major

The risk or severity of nephrotoxicity can be increased when Tobramycin is combined with Neomycin.

Tenofovir

Major

Tobramycin may increase the nephrotoxic activities of Tenofovir.

Tenofovir alafenamide

Major

Tobramycin may increase the nephrotoxic activities of Tenofovir alafenamide.

Tenofovir disoproxil

Major

Tobramycin may increase the nephrotoxic activities of Tenofovir disoproxil.

Vibrio cholerae CVD 103-HgR strain live antigen

Major

The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tobramycin.

Tobrex Toxicity & Overdose Risk

Tobramycin can be toxic in large doses and may cause serious side effects such as kidney damage, hearing loss, muscle weakness, and difficulty breathing. Treatment may involve supportive care and dialysis to remove the drug from the body. It is difficult to overdose on tobramycin, as it is not well absorbed in the digestive system. Animal studies have shown that orally administered LD50 values are greater than 7500 mg/kg.

Tobrex Novel Uses: Which Conditions Have a Clinical Trial Featuring Tobrex?

8 active clinical trials are currently being conducted to assess the applicability of Tobrex in the management of Cystic Fibrosis, Ocular Bacterial Infections and Bacterial Infections.

Condition

Clinical Trials

Trial Phases

Bacterial Infections

0 Actively Recruiting

Meningitis, Bacterial

0 Actively Recruiting

Bacteria

0 Actively Recruiting

Inflammation

0 Actively Recruiting

Eye Infections

0 Actively Recruiting

concomitant use of NSAID

0 Actively Recruiting

Cystic Fibrosis

0 Actively Recruiting

Osteomyelitis

0 Actively Recruiting

Burkholderia Cepacia Infection

0 Actively Recruiting

Adrenal Cortex Hormones

0 Actively Recruiting

Bacterial Peritonitis

0 Actively Recruiting

FEV1 <25% predicted

0 Actively Recruiting

ocular bacterial infections

0 Actively Recruiting

Urinary tract infection

0 Actively Recruiting

Eye Infections, Bacterial

0 Actively Recruiting

Cystic Fibrosis

0 Actively Recruiting

Intraabdominal Infections

1 Actively Recruiting

Not Applicable

Septicemia

0 Actively Recruiting

External auditory canal structure

0 Actively Recruiting

Otitis

0 Actively Recruiting

Tobrex Reviews: What are patients saying about Tobrex?

5

Patient Review

3/7/2009

Tobrex for Combined Inflammation of Cornea and Conjunctiva of the Eye

After just two days of using Tobrex, my eyes felt completely healed. Just make sure to follow your doctor's orders and finish the entire course of treatment.

4.3

Patient Review

6/17/2010

Tobrex for Inflammation of Eyelid Edges and the Lining of the Eye

My granddaughter had an inflammation on the edge of her eyelid (it may have been a sty) and this ointment cleared it up in just a few days. I only wish that the doctor had given us more specific instructions on how long to use the ointment, as neither the online information nor the prescription from the pharmacist said how many days to treat it.

4

Patient Review

10/17/2012

Tobrex for Inflammation of Eyelid Edges and the Lining of the Eye

The drug is effective, but I was shocked at how much it cost for such a small tube.

4

Patient Review

9/19/2010

Tobrex for Bacterial Infection of the Eyelid

Tobrex ointment is easy enough to apply at home, and it did help with the infection. However, we experienced some inflammation, redness, and pain as side effects. I would suggest considering this before use.

2.3

Patient Review

6/17/2014

Tobrex for Inflammation of Cornea due to Improper Closing of the Eye

I had an allergic reaction characterized by swelling of the face, throat, and eyes. Do not use if you're allergic to sulfur!

2

Patient Review

12/15/2008

Tobrex for Pink Eye from Bacterial Infection

This medication would be great if it weren't so difficult to administer to a young child. It's hard enough to get them to sit still, let alone hold their eye open long enough to put the ointment in.

1.7

Patient Review

6/24/2021

Tobrex for Inflammation of Eyelid Edges and the Lining of the Eye

I took this medication for a week and it was awful. A month later, my eye lid Buffyness cleared up but I've had blurred vision ever since. My optometrist says everything looks fine, but the blurred vision has reduced my sight by two times. Do not take this medicine!

1.3

Patient Review

7/25/2017

Tobrex for Inflammation of Eyelid Edges and the Lining of the Eye

Despite my use of this medication as directed for over a year, it has failed to produce results. My ophthalmologist refuses to prescribe anything else, which is frustrating given the high cost of this medication.

1

Patient Review

6/17/2014

Tobrex for Combined Inflammation of Cornea and Conjunctiva of the Eye

Tobramycin caused my throat and face to swell up. My eyes are now extremely swollen and my face is burning. I would not recommend this medication to anyone.

Patient Q&A Section about tobrex

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of Tobrex?

"If you experience any of the following symptoms, you may have eye allergies: itching or redness in the eyes; mild burning, stinging, or irritation; itchy or puffy eyelids; blurred vision; or increased sensitivity to light."

Answered by AI

How long should you use Tobrex eye drops?

"One drop should be put into the eye(s) every 4 to 6 hours while the patient is awake. For the first 24 to 48 hours, the amount may be increased to one drop every 2 hours while the patient is awake. The medicine should be taken for 14 days, but no more than 24 days."

Answered by AI

What is Tobrex used for?

"Tobrex is a drug used to treat bacterial infections of the external part of the eye. It contains tobramycin, which is an "aminoglycoside" antibiotic. Your doctor will have examined your eye(s) and decided that Tobrex is the right medicine for you before prescribing it."

Answered by AI

Is Tobrex an antibiotics?

"Tobrex is an antibiotic eye ointment used to treat bacterial infections."

Answered by AI

Clinical Trials for Tobrex

Image of UPMC-Presbyterian Hospital in Pittsburgh, United States.

Blue Light for Infections

18 - 65
All Sexes
Pittsburgh, PA

Our data suggest that modulating the characteristics of light carries the potential to modify the host response to injury and critical illness and thus, improve outcome. The ability to modify the host response to the stress of major operations and sepsis carries immense potential to improve patient care. The primary purpose of this study is to determine if exposure to bright blue (442nm) enriched light, by comparison to ambient white fluorescent light, reduces the inflammatory response or organ dysfunction in patients undergoing 1) medical treatment for pneumonia, 2) a 2-stage arthroplasty for surgical management of a septic joint, 3) surgery for a necrotizing soft tissue infection (NSTI), and 4) surgery for an intraabdominal infection (e.g., diverticulitis). We will expose participants to one of two (2) lighting conditions: 1) high illuminance (\~1700 lux,), blue (442nm) spectrum enriched light and 2) ambient white fluorescent light that provides the standard environmental lighting (\~300-400 lux, no predominant spectrum) of the hospital. Both cohorts will be exposed to a 12 hours:12 hours light:dark cycle photoperiod. Those subjects assigned to blue light will be asked to shine this small portable blue enriched light on themselves from 0800 to 2000 for 3 days. At the transition from light to dark, the blue-enriched light is turned off, and additional blue wavelength light removed with an amber filter. Thus, the total period of intervention is 72 hours. The outcome of interest is change in the inflammatory response after surgery for appendicitis or diverticulitis as measured by the following parameters: white blood cell count, heart rate, the development of abdominal abscess, serum cytokine concentrations. The outcome of interest is change in the inflammatory response during pneumonia as measured by the following parameters: white blood cell count, heart rate, and serum cytokine concentrations.

Recruiting
Has No Placebo

UPMC-Presbyterian Hospital (+2 Sites)

Matthew R Rosengart, MD MPH